Movement Alert|Beam Therapeutics, Inc. Intraday Rise 6.83%, sickle cell therapy progress continues to support sentiment

Market Focus
Nov 18

On November 18, Beam Therapeutics, Inc. rose 6.83% in Regular Trading, trading at $22.06 per share, with turnover of $3.9554 million.

The move followed continued market attention on positive progress for the company’s sickle cell disease candidate risto-cel, as investors reassessed the commercialization potential of its base editing platform.

Background context indicates the BEACON Phase 1/2 trial for risto-cel met primary efficacy and safety endpoints and achieved all secondary endpoints, with the company planning to submit a BLA to the FDA before year-end. At the same time, Beam Therapeutics, Inc. previously reported a quarterly loss of $1.28 per share, wider than the $1.15 loss expected, while a recent analyst consensus update also turned more conservative on next year revenue expectations. The share rise suggests the clinical milestone remained the more immediate focal point for trading.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10